Danny Hsu: Fascinating Insight into the Cellular Mechanisms of Statins in APLS
Danny Hsu, President of THANZ, reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
”Fascinating insight into the cellular mechanisms of statins in APLS.”
Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post:
”Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies
By Dominika Marova, Paul Frankenbach, Dr. Anne Hollerbach, Susanne Strand, Wolfram Ruf, Karl Lackner, and Nadine Müller Calleja
Antiphospholipid antibodies (aPLs) drive thrombosis and inflammation via endothelial protein C-receptor (EPCR)–mediated binding of lysobisphosphatidic acid (LBPA).
Statins may exert direct anti-APS effects through molecular competition at EPCR–lipid interfaces, not merely via lipid-lowering or pleiotropic vascular actions.”
Read the full article here.
Article: Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies
Authors: Dominika Marova, Paul Frankenbach, Anne Hollerbach, Susanne Strand, Wolfram Ruf, Karl J. Lackner, Nadine Müller-Calleja
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 13:40Caylynn Carls: Why Genetic Counseling Matters in Hemophilia Treatment
-
Jun 26, 2026, 13:25Ángel Cabrera: Clotting Disorders Behind Heavy Menstrual Bleeding
-
Jun 26, 2026, 13:02Turid Kjellevold: The Critical Role of Timely Hemostasis Testing
-
Jun 26, 2026, 10:59Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
-
Jun 26, 2026, 10:52Chinua Onyebuchi: The Future of Stroke Care in Africa Lies in Strong Health Systems
-
Jun 26, 2026, 10:35Habtamu Milkias Wolde: New Insights into Stroke and Traumatic Brain Injury from Global Burden of Disease Data
-
Jun 26, 2026, 10:19Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region
-
Jun 26, 2026, 10:11Kayla Kilani: First-Ever CT Perfusion Scan Performed Inside a Mobile Stroke Unit
-
Jun 26, 2026, 07:38Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST